The University of Waterloo spinout has been backed by university-linked investors as it prepares to expand its range of biosensor nanotechnology products.
Nicoya Lifesciences, a Canada-based biosensor nanotechnology spinout from University of Waterloo, has secured C$2m ($1.6m) from investors including University of Waterloo Student Venture Fund and the university-focused syndicate Waterloo Alumni Angels, Betakit has reported.
The round was co-led by VC firm Ripple Ventures and syndicate Golden Triangle Angel Network.
Wilfrid Laurier University’s Startup Fund also backed the round, as did the Mars Investment Accelerator Fund, state-owned economic development agency Business Development Bank of Canada, Garage Capital, Angel One,…